JP6547324B2 - Liquid oral composition - Google Patents

Liquid oral composition Download PDF

Info

Publication number
JP6547324B2
JP6547324B2 JP2015028458A JP2015028458A JP6547324B2 JP 6547324 B2 JP6547324 B2 JP 6547324B2 JP 2015028458 A JP2015028458 A JP 2015028458A JP 2015028458 A JP2015028458 A JP 2015028458A JP 6547324 B2 JP6547324 B2 JP 6547324B2
Authority
JP
Japan
Prior art keywords
composition
liquid oral
mass
oral cavity
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015028458A
Other languages
Japanese (ja)
Other versions
JP2016150912A (en
Inventor
友美子 平嶋
友美子 平嶋
赤羽 康宏
康宏 赤羽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lion Corp
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Priority to JP2015028458A priority Critical patent/JP6547324B2/en
Priority to PCT/JP2016/054370 priority patent/WO2016133063A1/en
Priority to CN201680010823.XA priority patent/CN107249546B/en
Priority to KR1020177021898A priority patent/KR102491340B1/en
Priority to MYPI2017702777A priority patent/MY183114A/en
Publication of JP2016150912A publication Critical patent/JP2016150912A/en
Application granted granted Critical
Publication of JP6547324B2 publication Critical patent/JP6547324B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)

Description

本発明は、知覚過敏抑制効果及び口腔内の浮遊菌殺菌効果が優れる硝酸カリウム含有のエタノール無配合の液体口腔用組成物に関する。   The present invention relates to a potassium nitrate-containing ethanol-free liquid oral cavity composition containing potassium nitrate, which is excellent in the hypersensitivity suppressing effect and the floating bacteria killing effect in the oral cavity.

象牙質知覚過敏症の予防策として、有効成分として公知の硝酸カリウムが口腔用組成物に配合される(特許文献1、2)。この硝酸カリウムは、口腔用組成物に一般的に配合されるラウリル硫酸ナトリウム存在下で不溶性析出物を生成するという問題があり、特許文献3では、硝酸カリウム及びラウリル硫酸ナトリウム含有の口腔用組成物に多価アルコール、両性界面活性剤を配合することによって、ラウリル硫酸カリウムの析出を防止し、低温析出を抑制している。
また、特に液体口腔用組成物での知覚過敏の抑制には、粘膜刺激の少なく低刺激性であるノンアルコールタイプの液体製剤がより好適である。
As a preventive measure of dentine hypersensitivity, potassium nitrate known as an active ingredient is blended in a composition for oral cavity (Patent Documents 1 and 2). This potassium nitrate has a problem that an insoluble precipitate is formed in the presence of sodium lauryl sulfate which is generally blended in oral compositions, and in Patent Document 3, potassium nitrate and sodium lauryl sulfate containing oral compositions are frequently used. By blending a polyhydric alcohol and an amphoteric surfactant, precipitation of potassium lauryl sulfate is prevented and precipitation at low temperature is suppressed.
In addition, non-alcoholic liquid preparations that are less irritating to mucous membranes and are less irritating are more suitable for suppressing hypersensitivity in particular in liquid oral compositions.

一方、カチオン性殺菌剤の塩化セチルピリジニウムは、口腔内の浮遊細菌への殺菌効果が優れ、う蝕等の口腔疾患の予防又は抑制に有効であるが、界面活性剤の影響を受け易く、特許文献4には、ビグアニド系のカチオン性殺菌剤と非イオン性界面活性剤を含有する口腔用組成物に特定化合物を添加し、非イオン性界面活性剤によるカチオン性殺菌剤の失活を防止し安定化配合した技術が提案されている。   On the other hand, cetyl pyridinium chloride, a cationic bactericidal agent, has excellent bactericidal effects on suspended bacteria in the oral cavity and is effective for the prevention or suppression of oral diseases such as caries, but is easily affected by surfactants, resulting in In Document 4, a specific compound is added to an oral composition containing a biguanide cationic bactericide and a nonionic surfactant to prevent the deactivation of the cationic bactericide by the nonionic surfactant. Stabilized compounding techniques have been proposed.

米国特許第3,863,006号U.S. Pat. No. 3,863,006 特開平7−101842号公報Japanese Patent Application Laid-Open No. 7-101842 特開2005−68071号公報JP, 2005-68071, A 特開昭60−255717号公報Japanese Patent Application Laid-Open No. 60-255717 特開2013−35792号公報JP, 2013-35792, A 特開2007−84471号公報JP 2007-84471 A

従って、硝酸カリウムを配合したノンアルコールタイプの液体口腔用製剤で知覚過敏を抑制し、かつ同時に口腔内浮遊菌に対して高い殺菌力を発揮できれば、口腔疾患の予防又は抑制により有効であり、このような液体口腔用製剤の開発が望まれた。   Therefore, if it is possible to suppress hypersensitivity with a non-alcohol type liquid oral preparation containing potassium nitrate and at the same time exert a high bactericidal activity against orally floating bacteria, it is more effective for prevention or suppression of oral diseases. It is desirable to develop a suitable liquid oral preparation.

本発明は、上記事情に鑑みなされたもので、知覚過敏抑制効果及び口腔内の浮遊菌殺菌効果が優れる硝酸カリウム含有のエタノール無配合の液体口腔用組成物を提供することを目的とする。   This invention is made in view of the said situation, and an object of this invention is to provide the composition for liquid oral cavity containing no potassium nitrate containing potassium which is excellent in the hypersensitivity suppression effect and the floating microbe killing effect in the oral cavity.

本発明者らは、上記目的を達成するため鋭意検討を行った結果、(A)硝酸カリウムと(B)塩化セチルピリジニウムとを配合したエタノール無配合の液体口腔用組成物に、(C)非イオン界面活性剤及び(D)両性界面活性剤を配合し、(E)水分量を55質量%以上92質量%未満とし、組成物のpHを6.8以上8.0未満とすることによって、(A)、(B)成分の併用によって生じる不溶性沈殿物の析出が抑制され、知覚過敏抑制効果及び口腔内の浮遊菌殺菌効果が優れるノンアルコールタイプの液体口腔用組成物が得られ、知覚過敏及びう蝕の抑制に好適に使用し得ることを知見し、本発明をなすに至った。   The inventors of the present invention conducted intensive studies to achieve the above object, and as a result, a liquid oral composition containing no (A) potassium nitrate and (B) cetyl pyridinium chloride in a liquid oral composition containing no ethanol (C) non-ionic By blending the surfactant and (D) amphoteric surfactant, (E) making the water content 55% by mass or more and less than 92% by mass, and making the pH of the composition 6.8 or more and less than 8.0, A) The composition of the non-alcohol type liquid oral cavity composition is obtained which suppresses the precipitation of insoluble precipitates generated by the combined use of the components (B) and is excellent in the hypersensitivity suppressing effect and the floating bacteria killing effect in the oral cavity. The present inventors have found that the present invention can be suitably used for the inhibition of caries.

即ち、硝酸カリウム含有の液体口腔用組成物に、カチオン性殺菌剤の塩化セチルピリジニウムを配合することで、知覚過敏抑制効果及び口腔内の浮遊菌殺菌効果を付与できると予想されるが、硝酸カリウムと塩化セチルピリジニウムとをエタノール含有液体口腔用組成物中に配合する場合は全く問題が生じないにもかかわらず、低刺激のエタノール無配合の液体口腔用組成物に硝酸カリウムと塩化セチルピリジニウムとを併用して配合すると、不溶性沈殿物が産生されて析出し、これによって、知覚過敏抑制効果が低下し、殺菌効果も十分に発現しなくなるという問題が生じることを知見した。このため、エタノール無配合の液体口腔用組成物中で硝酸カリウムと塩化セチルピリジニウムとを不溶性沈殿物が析出なしに併用し、硝酸カリウムと塩化セチルピリジニウムの良好な作用効果を発揮させるという新たな課題が浮上した。そこで、これらの課題を解消するため、本発明者らが更に検討を進めた結果、(C)非イオン界面活性剤と(D)両性界面活性剤とを組み合わせて添加し、組成物中の水分量、pHを上記範囲内にすることによって、上記した(A)、(B)成分の併用によって生じる不溶性沈殿物の析出が抑制され、高い知覚過敏抑制効果及び浮遊菌殺菌効果を同時に付与することができ、また、外観を安定に維持し、苦味を抑えて良好な使用感を与えることもできた。この場合、塩化セチルピリジニウムは非イオン界面活性剤等の界面活性剤による影響を受けて失活し易いにもかかわらず、本発明においては、(C)、(D)成分の界面活性剤の組み合わせが、組成物中の水分量、pHが特定範囲内で特異的に作用し、上記格別かつ顕著な作用効果を与える。
従って、本発明のエタノール無配合の液体口腔用組成物は、後述の実施例からも明らかなように、液体口腔用組成物を調製して4週間経過後に不溶性沈殿物の析出がほとんどなく外観が経時で安定であり、知覚過敏抑制効果及び口腔内の浮遊菌殺菌効果が高く、また、使用後の苦味が抑制され味の良い良好な使用感を有する。
That is, it is expected that the addition of the cationic bactericidal agent cetyl pyridinium chloride to the liquid composition for oral cavity containing potassium nitrate can impart the hypersensitivity suppressing effect and the floating bacteria killing effect in the oral cavity, but potassium nitrate and chloride Even though there is no problem at all when cetyl pyridinium is blended in the ethanol-containing liquid oral composition, the combination of potassium nitrate and cetyl pyridinium chloride in a low-stimulus ethanol-free liquid oral composition It has been found that, when incorporated, an insoluble precipitate is produced and precipitated, which causes a problem that the hypersensitivity suppressing effect is reduced and the bactericidal effect is not sufficiently expressed. For this reason, the new problem that potassium nitrate and cetyl pyridinium chloride are used in combination without insoluble precipitates in the composition for liquid oral cavity not containing ethanol, and the good function and effect of potassium nitrate and cetyl pyridinium chloride is exhibited did. Then, as a result that the present inventors advanced examination further in order to solve these subjects, it combines and adds (C) nonionic surfactant and (D) amphoteric surfactant, and the water | moisture content in a composition is added. By setting the amount and pH within the above range, precipitation of the insoluble precipitate generated by the combined use of the components (A) and (B) described above is suppressed, and a high hypersensitivity suppressing effect and a suspended germ killing effect are simultaneously provided. It was also possible to keep the appearance stable and suppress the bitter taste to give a good feeling of use. In this case, although cetyl pyridinium chloride is easily inactivated under the influence of a surfactant such as a nonionic surfactant, in the present invention, a combination of surfactants of components (C) and (D) is used. However, the amount of water in the composition and the pH act specifically within a specific range to give the above-mentioned remarkable and remarkable effects.
Therefore, the composition for liquid oral cavity containing no ethanol according to the present invention has almost no precipitation of insoluble precipitates after 4 weeks after preparation of the composition for liquid oral cavity, as apparent from the examples described later. It is stable over time, has a high hypersensitivity suppressing effect and a high ability to kill suspended bacteria in the oral cavity, and has a good taste after use, with suppressed bitter taste.

なお、特許文献3は、口腔用組成物において硝酸カリウム及びラウリル硫酸ナトリウムの併用によって生じるラウリル硫酸カリウムの析出を抑制したものであり、また、特許文献4は、非イオン界面活性剤によるカチオン性殺菌剤の失活防止であり、カチオン性殺菌剤を硝酸カリウムに併用することについて言及されていない。特許文献5、6には、硝酸カリウム、塩化セチルピリジニウムを配合した液体口腔用組成物が記載されているが、これらはエタノール配合組成である。特許文献3〜6から、エタノール無配合の液体口腔用組成物における硝酸カリウムと塩化セチルピリジニウムとの併用によって生じる不溶性沈殿物の析出抑制は予測できない。   In addition, patent document 3 suppresses precipitation of potassium lauryl sulfate which is generated by the combined use of potassium nitrate and sodium lauryl sulfate in the composition for oral cavity, and patent document 4 is a cationic bactericidal agent using a nonionic surfactant. No mention is made of using cationic bactericides in combination with potassium nitrate. Patent Literatures 5 and 6 describe liquid oral cavity compositions containing potassium nitrate and cetyl pyridinium chloride, but these are ethanol-blended compositions. From patent documents 3-6, precipitation control of the insoluble precipitate which arises by combined use of potassium nitrate and cetyl pyridinium chloride in the composition for liquid oral cavity do not mix can not be predicted.

従って、本発明は、下記の液体口腔用組成物及び該組成物における不溶性沈殿物の析出抑制方法を提供する。
〔1〕
(A)硝酸カリウムを0.01〜10質量%及び(B)塩化セチルピリジニウムを0.001〜0.1質量%配合したエタノール無配合の液体口腔用組成物に、
(C)エチレンオキサイドの平均付加モル数が40〜100モルのポリオキシエチレン硬化ヒマシ油を0.2〜2質量%、及び
(D)アルキルアミドベタイン又はその塩を0.2〜2質量%
配合し、(E)水分量を55質量%以上92質量%未満とし、組成物の25℃におけるpHを6.8以上8.0未満としたことを特徴とする液体口腔用組成物。
〔2〕
(A)硝酸カリウムを0.01〜10質量%及び(B)塩化セチルピリジニウムを0.001〜0.1質量%配合したエタノール無配合の液体口腔用組成物に、
(C)エチレンオキサイドの平均付加モル数が40〜100モルのポリオキシエチレン硬化ヒマシ油を0.2〜2質量%、及び
(D)アルキルアミドベタイン又はその塩を0.2〜2質量%
配合し、(E)水分量を55質量%以上92質量%未満とし、組成物の25℃におけるpHを6.8以上8.0未満とすることを特徴とする、前記液体口腔用組成物における(A)硝酸カリウム及び(B)塩化セチルピリジニウムの併用によって生じる不溶性沈殿物の析出抑制方法。
Accordingly, the present invention provides the following composition for liquid oral cavity and a method for suppressing precipitation of insoluble precipitates in the composition.
[1]
A liquid oral composition containing no (A) potassium nitrate in an amount of 0.01 to 10% by mass and (B) cetylpyridinium chloride in an amount of 0.001 to 0.1% by mass.
(C) the average number of moles of added ethylene oxide is 40 to 100 moles of polyoxyethylene hydrogenated castor oil 0.2 to 2% by weight, and (D) an alkyl amido betaine or a salt thereof from 0.2 to 2 wt%
(E) A composition for liquid oral cavity comprising: (E) a water content of 55% by mass to less than 92% by mass, and a pH of the composition at 25 ° C. of 6.8 to less than 8.0.
[2]
A liquid oral composition containing no (A) potassium nitrate in an amount of 0.01 to 10% by mass and (B) cetylpyridinium chloride in an amount of 0.001 to 0.1% by mass.
(C) the average number of moles of added ethylene oxide is 40 to 100 moles of polyoxyethylene hydrogenated castor oil 0.2 to 2% by weight, and (D) an alkyl amido betaine or a salt thereof from 0.2 to 2 wt%
In the composition for a liquid oral cavity, it is characterized in that (E) the water content is 55% by mass to less than 92% by mass, and the pH of the composition at 25 ° C. is 6.8 or more and less than 8.0. The precipitation suppression method of the insoluble precipitate produced by combined use of (A) potassium nitrate and (B) cetyl pyridinium chloride.

本発明によれば、知覚過敏抑制効果及び口腔内の浮遊菌殺菌効果が優れる硝酸カリウム含有のエタノール無配合の液体口腔用組成物を提供できる。   According to the present invention, it is possible to provide a potassium nitrate-containing ethanol-free liquid oral composition containing potassium nitrate which is excellent in the hypersensitivity suppressing effect and the floating bacteria killing effect in the oral cavity.

以下、本発明について更に詳述する。本発明の液体口腔用組成物は、(A)硝酸カリウム、(B)塩化セチルピリジニウム、(C)非イオン界面活性剤、(D)両性界面活性剤、(E)水を含有し、エタノール無配合である。   Hereinafter, the present invention will be described in more detail. The liquid composition for oral cavity of the present invention contains (A) potassium nitrate, (B) cetyl pyridinium chloride, (C) non-ionic surfactant, (D) amphoteric surfactant, (E) water, and contains no ethanol. It is.

(A)硝酸カリウムは、象牙質知覚過敏症を予防又は治療するための有効成分として配合されるものであり、知覚過敏抑制剤である。
(A)成分の硝酸カリウムの配合量は、組成物全体の0.01〜10%(質量%、以下、同様。)が好ましく、より好ましくは0.1〜7%である。配合量が多いほど知覚過敏抑制効果は高まるが、10%以下であることが、十分な析出抑制、苦味の抑制にはより好適である。
(A) Potassium nitrate is formulated as an active ingredient for preventing or treating dentine hypersensitivity and is a hypersensitivity inhibitor.
The blending amount of potassium nitrate as the component (A) is preferably 0.01 to 10% (% by mass, hereinafter, the same) of the whole composition, and more preferably 0.1 to 7%. The greater the compounding amount, the higher the hypersensitivity-suppressing effect, but 10% or less is more suitable for sufficient precipitation suppression and bitterness suppression.

(B)塩化セチルピリジニウムは、カチオン性殺菌剤であり、口腔内浮遊菌に対する殺菌剤である。塩化セチルピリジニウムは、市販のものを使用できる。
(B)成分の塩化セチルピリジニウムの配合量は、組成物全体の0.001〜0.1%が好ましく、より好ましくは0.005〜0.1%、さらに好ましくは0.01〜0.05%である。多く配合するほど殺菌効果が高まるが、0.1%以下であることが、十分な析出抑制、苦味の抑制にはより好適である。
(B) Cetyl pyridinium chloride is a cationic bactericidal agent and is a bactericidal agent against orally floating bacteria. Commercially available cetyl pyridinium chloride can be used.
The blending amount of cetyl pyridinium chloride as the component (B) is preferably 0.001 to 0.1%, more preferably 0.005 to 0.1%, still more preferably 0.01 to 0.05 of the whole composition. %. The more the compounding effect is, the higher the bactericidal effect is, but 0.1% or less is more suitable for sufficiently suppressing precipitation and suppressing bitterness.

本発明では、(C)非イオン界面活性剤及び(D)両性界面活性剤を組み合わせて配合することが効果発現に重要である。(C)成分又は(D)成分を欠くと、不溶性沈殿物が析出し、知覚過敏抑制効果及び浮遊菌殺菌効果が劣る。また、苦味が抑制されず使用感が劣る。   In the present invention, it is important to exert the effect by combining the (C) nonionic surfactant and the (D) amphoteric surfactant. In the absence of the component (C) or the component (D), an insoluble precipitate is deposited, and the hypersensitivity-suppressing effect and the suspended germ killing effect are inferior. In addition, the bitter taste is not suppressed and the feeling of use is inferior.

(C)非イオン界面活性剤としては、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンアルキルエーテル、ポリグリセリン脂肪酸エステルが挙げられ、これらの1種又は2種以上を使用し得るが、特に、エチレンオキサイド(E.O.)の平均付加モル数が40〜100モル、特に60〜100モルのポリオキシエチレン硬化ヒマシ油、アルキル基の炭素数が16〜18でE.O.の平均付加モル数が10〜40モル、特に20〜40モルのポリオキシエチレンアルキルエーテル、脂肪酸の炭素数が12〜18、特に12〜14のデカグリセリンモノ脂肪酸エステルポリグリセリン脂肪酸エステルが好ましく、中でもE.O.の平均付加モル数が40〜100モルのポリオキシエチレン硬化ヒマシ油が好ましい。   (C) Examples of the nonionic surfactant include polyoxyethylene hydrogenated castor oil, polyoxyethylene alkyl ether and polyglycerin fatty acid ester, and one or more of them may be used, and in particular ethylene oxide. The average addition mole number of (E.O.) is 40 to 100 moles, particularly 60 to 100 moles of polyoxyethylene hydrogenated castor oil, the carbon number of the alkyl group is 16 to 18, and E.O. O. Polyoxyethylene alkyl ethers having an average added mole number of 10 to 40 moles, particularly 20 to 40 moles, and decaglycerin mono fatty acid esters polyglycerin fatty acid esters having 12 to 18 carbon atoms, particularly 12 to 14 carbon atoms of fatty acids are preferred, among E. O. Polyoxyethylene hydrogenated castor oil having an average added mole number of 40 to 100 moles is preferable.

具体的には、商品化されている下記に示すような市販品を使用することができる。
ポリオキシエチレン硬化ヒマシ油;
日光ケミカルズ社製のNIKKOL HCO系、日本エマルジョン社製のエマレックスHC系、日本油脂社製のユニオックスHC系
ポリオキシエチレンアルキルエーテル;
日光ケミカルズ社製のNIKKOL BC系、NIKKOL BS系、日本エマルジョン社製のエマレックス100系、エマレックス600系
デカグリセリンモノ脂肪酸エステル;
日光ケミカルズ社製のNIKKOL Decagln系、三菱化学フーズ社製のリョートー(登録商標)ポリグリエステルDシリーズ
Specifically, commercially available commercial products as shown below can be used.
Polyoxyethylene hydrogenated castor oil;
NIKKOL HCO system manufactured by Nikko Chemicals, Emarex HC system manufactured by Nippon Emulsion, Uniox HC system polyoxyethylene alkyl ether manufactured by Nippon Oil and Fats Co.
NIKKOL BC system manufactured by Nikko Chemicals, NIKKOL BS system, Emarex 100 system manufactured by Nippon Emulsion Co., Ltd. Emarex 600 system decaglycerin mono fatty acid ester;
NIKKOL Decagln series manufactured by Nikko Chemicals Co., Ltd. and Ryoto (registered trademark) polyglyester D series manufactured by Mitsubishi Chemical Foods Co., Ltd.

(C)成分の非イオン界面活性剤の配合量は、組成物全体の0.1〜2%が好ましく、より好ましくは0.1〜1%、さらに好ましくは0.2〜0.5%である。0.1%以上配合すると、十分な析出抑制効果、知覚過敏抑制効果及び浮遊菌殺菌効果を奏し、また、苦味を十分に抑制できる。2%以下であることが、知覚過敏抑制効果及び浮遊菌殺菌効果が低下するのを防止するにはより好適である。   The blending amount of the nonionic surfactant of the component (C) is preferably 0.1 to 2% of the whole composition, more preferably 0.1 to 1%, and still more preferably 0.2 to 0.5%. is there. When 0.1% or more is blended, sufficient precipitation suppressing effect, hypersensitivity suppressing effect and suspended bacteria killing effect can be exhibited, and bitter taste can be sufficiently suppressed. It is more suitable for preventing that a hypersensitivity inhibitory effect and a floating microbe bactericidal effect fall that it is 2% or less.

(D)両性界面活性剤としては、ヤシ油脂肪酸アミドプロピルベタイン等のアルキルアミドベタイン又はその塩、ラウリルジメチルアミノ酢酸ベタイン等の酢酸ベタイン型、N−脂肪酸アシル−N−カルボキシメチル−N−ヒドロキシエチルエチレンジアミン塩等のイミダゾリン型、N−脂肪酸アシル−L−アルギネート塩等のアミノ酸型などが挙げられ、これらの1種又は2種以上を使用し得るが、特に、アルキルアミドベタイン又はその塩が好ましく、中でも、ヤシ油脂肪酸アミドプロピルベタインが好適である。
具体的には、ヤシ油脂肪酸アミドプロピルベタイン(デグッサ社製のTEGO Betain CK OK(30%水溶液)、花王(株)製のアンヒトール55AB(30%水溶液))などの市販品を使用し得る。
(D) As amphoteric surfactants, alkylamide betaines such as coconut oil fatty acid amidopropyl betaine or salts thereof, betaine acetate type such as lauryl dimethylaminoacetic acid betaine, N-fatty acid acyl-N-carboxymethyl-N-hydroxyethyl The imidazoline type such as ethylene diamine salt, the amino acid type such as N-fatty acid acyl-L-alginate salt, etc. may be mentioned, and one or two or more of them may be used, and alkylamide betaine or its salt is particularly preferable. Among them, coconut oil fatty acid amidopropyl betaine is preferred.
Specifically, commercial products such as coconut oil fatty acid amidopropyl betaine (TEGO Betain CK OK (30% aqueous solution manufactured by Degussa), Anthol 55 AB (30% aqueous solution) manufactured by Kao Corporation) can be used.

(D)成分の両性界面活性剤の配合量は、組成物全体の0.1〜2%が好ましく、より好ましくは0.1〜1%、さらに好ましくは0.2〜0.5%である。0.1%以上配合すると、十分な析出抑制効果、知覚過敏抑制効果及び浮遊菌殺菌効果を奏し、また、苦味を十分に抑制できる。2%以下であることが、知覚過敏抑制効果及び浮遊菌殺菌効果が低下するのを防止するにはより好適である。   The blending amount of the amphoteric surfactant of the component (D) is preferably 0.1 to 2%, more preferably 0.1 to 1%, and still more preferably 0.2 to 0.5% of the whole composition. . When 0.1% or more is blended, sufficient precipitation suppressing effect, hypersensitivity suppressing effect and suspended bacteria killing effect can be exhibited, and bitter taste can be sufficiently suppressed. It is more suitable for preventing that a hypersensitivity inhibitory effect and a floating microbe bactericidal effect fall that it is 2% or less.

本発明の液体口腔用組成物は、(E)水の含有量、つまり組成物中の水分量が、組成物全体の55%以上92%未満であり、好ましくは60%以上91%以下、より好ましくは60%以上70%以下である。水分量が上記範囲内であると、不溶性沈殿物を析出抑制でき、優れた知覚過敏抑制効果及び苦味抑制効果を付与することができる。55%未満であると、析出抑制できず、知覚過敏抑制効果及び浮遊菌殺菌効果が劣る。92%以上であると、析出抑制効果が劣り、知覚過敏抑制効果及び浮遊菌殺菌効果も劣り、苦味を抑制することもできない。   The composition for a liquid oral cavity of the present invention has (E) water content, that is, the water content in the composition is 55% or more and less than 92% of the whole composition, preferably 60% or more and 91% or less Preferably it is 60% or more and 70% or less. An insoluble precipitate can be precipitation-suppressed as a water content is in the said range, and the outstanding hypersensitivity suppression effect and the bitter taste suppression effect can be provided. If it is less than 55%, the precipitation can not be suppressed, and the hypersensitivity-suppressing effect and the suspended germ killing effect are inferior. If it is 92% or more, the precipitation suppression effect is inferior, the hypersensitivity suppression effect and the floating bacteria sterilization effect are also inferior, and bitterness can not be suppressed.

本発明において、液体口腔用組成物のpHは6.8以上8.0未満であり、好ましくはpH6.8〜7.8、より好ましくはpH6.8〜7.5である。上記範囲内であると、析出抑制効果、知覚過敏抑制効果及び苦味抑制効果が優れる。pH6.8未満又はpH8.0以上であると、析出抑制できず、知覚過敏抑制効果及び浮遊菌殺菌効果が劣る。
なお、pHは、組成物を調製直後に東亜電波工業社製のpHメーター(型番Hm−30S)を用いて測定し、25℃、3分後の値である(以下、同様。)。
In the present invention, the pH of the liquid oral composition is 6.8 or more and less than 8.0, preferably 6.8 to 7.8, and more preferably 6.8 to 7.5. The precipitation inhibitory effect, the hypersensitivity inhibitory effect, and the bitter taste inhibitory effect are excellent in it being in the said range. If the pH is less than 6.8 or pH 8.0 or more, precipitation can not be suppressed, and the hypersensitivity-suppressing effect and the suspended germ killing effect are inferior.
The pH is a value measured at 25 ° C. for 3 minutes immediately after preparation of the composition using a pH meter (model Hm-30S) manufactured by Toa Denpa Kogyo Co., Ltd. (the same applies hereinafter).

本発明では、組成物のpHを上記範囲内に調整するのに、公知のpH調整剤を添加してもよい。例えばリン酸二水素ナトリウム等のリン酸水素アルカリ金属塩、水酸化ナトリウム等のアルカリ金属の水酸化物などが挙げられる。   In the present invention, known pH adjusters may be added to adjust the pH of the composition within the above range. For example, alkali metal hydrogenphosphates such as sodium dihydrogenphosphate and hydroxides of alkali metals such as sodium hydroxide can be mentioned.

本発明の液体口腔用組成物は、エタノール無配合である。ここで、「エタノール無配合」とは、エタノールが配合されないものであるが、液体口腔用組成物では、組成物中に配合される香料中に原料由来のエタノールが微量含まれる場合などがあるため、これらの理由を考慮した上で、香料中などに微量含有されるエタノール以外にエタノールを含まないものである。なお、この場合、組成物中のエタノール量は組成物全体に対して好ましくは100ppm以下、より好ましくは50ppm以下、さらに好ましくは10ppm以下である。
本発明では、このようなエタノール無配合の組成で、不溶性沈殿物の析出を抑制し、優れた知覚過敏抑制効果及び浮遊菌殺菌効果を奏する。
The composition for liquid oral cavity of the present invention does not contain ethanol. Here, "no ethanol blending" means that ethanol is not blended, but in the composition for liquid oral cavity, a small amount of ethanol derived from the raw material may be contained in the flavor blended in the composition. In consideration of these reasons, it does not contain ethanol other than ethanol contained in a trace amount in a perfume or the like. In this case, the amount of ethanol in the composition is preferably 100 ppm or less, more preferably 50 ppm or less, still more preferably 10 ppm or less, based on the entire composition.
In the present invention, with such a composition containing no ethanol, precipitation of insoluble precipitates is suppressed, and an excellent hypersensitivity suppressing effect and suspended bacteria killing effect are exhibited.

本発明の液体口腔用組成物は、特に洗口剤として好適である。また、本発明組成物には、上記成分に加えて、必要に応じてその他の公知成分を、本発明の効果を妨げない範囲で配合できる。具体的には、湿潤剤、溶剤、更に必要により甘味剤、着色剤、防腐剤、香料、有効成分等が配合される。
なお、液体口腔用組成物、特に洗口剤には、研磨剤などの可溶化しない固形成分は通常配合されず、研磨剤は含まないことが好ましい。
また、界面活性剤としては、(C)非イオン界面活性剤及び(D)両性界面活性剤以外の界面活性剤は配合しなくてもよいが、配合する場合は0.5%以下、特に0.05〜0.2%が望ましい。
The liquid oral cavity composition of the present invention is particularly suitable as a mouthwash. In addition to the above components, other known components can be added to the composition of the present invention, as needed, in a range that does not impair the effects of the present invention. Specifically, wetting agents, solvents, and, if necessary, sweeteners, coloring agents, preservatives, flavors, active ingredients and the like are blended.
In addition, it is preferable that the solid component which does not solubilize, such as an abrasive | polishing agent, is not normally mix | blended with the composition for liquid oral cavity, especially a mouthwash, and does not contain an abrasive | polishing agent normally.
Further, as the surfactant, a surfactant other than (C) nonionic surfactant and (D) amphoteric surfactant may not be blended, but in the case of blending it is 0.5% or less, particularly 0 .05-0.2% is desirable.

湿潤剤としては、例えばソルビトール等の糖アルコール、グリセリン、ポリエチレングリコール等の多価アルコールが挙げられる。これら湿潤剤の配合量は、通常、2〜40%である。   Examples of the wetting agent include sugar alcohols such as sorbitol, and polyhydric alcohols such as glycerin and polyethylene glycol. The blending amount of these wetting agents is usually 2 to 40%.

溶剤としては、精製水が一般的に用いられ、組成物中の水分量が上記範囲内で添加することができる。また、エタノール等の炭素数1〜3の低級一価アルコール、プロピレングリコール等を配合してもよい。   Purified water is generally used as a solvent, and the amount of water in the composition can be added within the above range. In addition, lower monohydric alcohols having 1 to 3 carbon atoms such as ethanol, propylene glycol and the like may be blended.

甘味剤としては、キシリトール、マルチトール、サッカリン、サッカリンナトリウム、ステビオサイド、アスパルテーム等を配合することができる。着色剤として、青色1号、緑色3号、黄色4号、赤色105号など、安全性の高い水溶性色素を添加することができる。防腐剤としては、パラオキシ安息香酸エステル、安息香酸又はその塩が挙げられる。   As a sweetening agent, xylitol, maltitol, saccharin, saccharin sodium, stevioside, aspartame etc. can be blended. As coloring agents, highly safe water-soluble dyes such as Blue No. 1, Green No. 3, Yellow No. 4, Red No. 105 can be added. Preservatives include p-oxybenzoic acid esters, benzoic acid or salts thereof.

香料としては、ペパーミント油、スペアミント油、ユーカリ油、ウィンターグリーン油、クローブ油、タイム油、セージ油、カルダモン油、ローズマリー油、マジョラム油、レモン油、ナツメグ油、ラベンダー油、パラクレス油等の天然精油、及びl−メントール、l−カルボン、シンナミックアルデヒド、オレンジオイル、アネトール、1,8−シネオール、メチルサリシレート、オイゲノール、チモール、リナロール、リモネン、メントン、メンチルアセテート、シトラール、カンファー、ボルネオール、ピネン、スピラントール等の上記天然精油中に含まれる香料成分、また、エチルアセテート、エチルブチレート、イソアミルアセテート、ヘキサナール、ヘキセナール、メチルアンスラニレート、エチルメチルフェニルグリシデート、ベンツアルデヒド、バニリン、エチルバニリン、フラネオール、マルトール、エチルマルトール、ガンマ/デルタデカラクトン、ガンマ/デルタウンデカラクトン、N−エチル−p−メンタン−3−カルボキサミド、メンチルラクテート、エチレングリコール−l−メンチルカーボネート等の香料成分、更には、いくつかの香料成分や天然精油を組み合わせてなる、アップル、バナナ、ストロベリー、ブルーベリー、メロン、ピーチ、パイナップル、グレープ、マスカット、ワイン、チェリー、スカッシュ、コーヒー、ブランデー、ヨーグルト等の調合フレーバーの1種又は2種以上を、組成物中0.00001〜3%で、本発明の効果を妨げない範囲で使用することができる。   As the flavor, peppermint oil, spearmint oil, eucalyptus oil, winter green oil, clove oil, thyme oil, sage oil, cardamom oil, rosemary oil, marjoram oil, lemon oil, lemon oil, nutmeg oil, lavender oil, paracres oil etc. Essential oils and l-menthol, l-carvone, cinnamic aldehyde, orange oil, anethole, 1,8-cineole, methyl salicylate, eugenol, thymol, linalool, limonene, menthone, menthyl acetate, citral, camphor, borneol, pinene, Flavor components contained in the above-mentioned natural essential oils such as spilanthol, and also ethyl acetate, ethyl butyrate, isoamyl acetate, hexanal, hexenal, methyl anthranilate, ethyl methyl phenyl glycidate Benzaldehyde, vanillin, ethyl vanillin, furaneol, maltol, ethyl maltol, gamma / delta decalactone, gamma / deltown decalactone, N-ethyl-p-menthane-3-carboxamide, menthyl lactate, ethylene glycol-l-mentyl carbonate Etc. Consists of fragrant ingredients such as, and, additionally, some fragrant ingredients and natural essential oils, apple, banana, strawberry, blueberry, melon, peach, pineapple, grape, muscat, wine, cherry, squash, coffee, brandy, yogurt And the like can be used in an amount of 0.00001 to 3% in the composition as long as the effects of the present invention are not impaired.

有効成分としては、硝酸カリウム、塩化セチルピリジニウムに加えて、イソプロピルメチルフェノール等の殺菌剤、トラネキサム酸、イプシロン−アミノカプロン酸等の抗炎症剤、デキストラナーゼ等の酵素、フッ化ナトリウム、モノフルオロリン酸ナトリウム等のフッ化物、アラントイン、ビタミンC等のビタミン類、銅化合物、植物抽出物等が挙げられる。なお、これらの有効成分の添加量は、本発明の効果を妨げない範囲とすることができる。   As an active ingredient, in addition to potassium nitrate and cetyl pyridinium chloride, a bactericidal agent such as isopropylmethylphenol, an anti-inflammatory agent such as tranexamic acid, epsilon-aminocaproic acid, an enzyme such as dextranase, sodium fluoride, monofluorophosphate Fluorides such as sodium, allantoin, vitamins such as vitamin C, copper compounds, plant extracts and the like can be mentioned. In addition, the addition amount of these active ingredients can be made into the range which does not prevent the effect of this invention.

以下、実施例及び比較例、処方例を示し、本発明を具体的に説明するが、本発明は下記の実施例に制限されるものではない。なお、下記の例において%は特に断らない限りいずれも質量%を示す。なお、pHは上記と同様に25℃において測定した。   EXAMPLES The present invention will be specifically described below by showing Examples, Comparative Examples, and Formulation Examples, but the present invention is not limited to the following Examples. In the following examples,% indicates% by mass unless otherwise specified. The pH was measured at 25 ° C. in the same manner as above.

[実施例、比較例]
表1、2に示す組成の液体口腔用組成物(洗口剤)を常法により調製した。得られた洗口剤について、下記の方法及び基準により評価を行ったところ、表1、2のような結果が得られた。
Example, Comparative Example
A liquid oral composition (mouthwash) having the composition shown in Tables 1 and 2 was prepared by a conventional method. The obtained mouthrinse was evaluated by the following method and criteria, and the results shown in Tables 1 and 2 were obtained.

(1)外観安定性(析出抑制効果)の評価方法
表に記載の各洗口剤を100mLのペットボトル中に80mL入れ、25℃恒温槽中に静置保存し、4週間後の外観を下記の評点基準に従い目視で判定した。5サンプルの平均値を求め、下記の評価基準に従って評価した。
評点基準:
4点:析出物が全くなかった
3点:析出物がわずかにあった
2点:析出物がややあった
1点:析出物がかなりあった
外観安定性(析出抑制効果)の評価基準:
◎:平均点3.5点以上4.0点以下
○:平均点3.0点以上3.5点未満
△:平均点2.0点以上3.0点未満
×:平均点2.0点未満
(1) Evaluation method of appearance stability (precipitation suppression effect) 80 mL of each mouthwash as described in the table is put in a 100 mL PET bottle, stored still in a 25 ° C. thermostat, and appearance after 4 weeks It judged visually according to the grading standard of. The average value of 5 samples was determined and evaluated according to the following evaluation criteria.
Rating criteria:
4 points: There was no precipitate 3 points: There was a slight precipitate 2 points: There was a slight precipitate 1 point: There was a large amount of precipitate Evaluation criteria of appearance stability (precipitation inhibition effect):
A: Average point 3.5 or more and 4.0 or less ○: Average point 3.0 or more and less than 3.5 points Δ: Average point 2.0 or more and less than 3.0 points ×: Average point 2.0 Less than

(2)知覚過敏抑制効果の評価方法
表に記載の各洗口剤を、象牙質知覚過敏を有する人5名に1ヶ月間、通常の方法で洗口して使用させ、知覚過敏の抑制効果を下記評点基準で判定した。被験者5名の平均値を求め、下記の評価基準に従って評価した。
知覚過敏抑制効果の評点基準:
3点:痛みを感じなくなった
2点:ほとんど痛みを感じなくなった
1点:痛みを感じる
知覚過敏抑制効果の評価基準:
◎:2.5点以上3.0点以下
○:2.0点以上2.5点未満
△:1.5点以上2.0点未満
×:1.5点未満
(2) Evaluation Method of Hypersensitivity Suppressive Effect Each mouthwash described in the table is used for 1 month cleaning of 5 persons with dentine hypersensitivity in the usual way, and the hypersensitivity suppressive effect Was determined according to the following rating criteria. The average value of 5 subjects was determined and evaluated according to the following evaluation criteria.
Rating criteria for hypersensitivity suppression effect:
3 points: I no longer feel pain 2 points: I hardly feel pain 1 point: I feel pain Evaluation criteria for hypersensitivity suppression effect:
:: 2.5 or more and 3.0 or less ○: 2.0 or more and less than 2.5 points △: 1.5 or more and less than 2.0 points ×: less than 1.5 points

(3)口腔内浮遊菌に対する殺菌効果の評価方法
使用した菌液は、培養液としてトリプチケースソイブロス(Difco社製)30gを1Lの精製水に溶解したものを、口腔常在細菌としてストレプトコッカス ミュータンスATCC10449株を用い、37℃、嫌気条件下(5容量%炭酸ガス、95容量%窒素)で1日培養した液の550nmでの透過度が20になるように生理食塩水を加えて調製した。サンプル(液体口腔用組成物)2.7mLに菌液0.3mLを加え、撹拌後、37℃で1分間反応させ、再び撹拌後、予め2.7mLの培養液の入った試験管を5本用意し、その1番目の試験管に、前記菌液を加えたサンプル0.3mLを加え、撹拌した。この液0.3mLを採取し、2番目の試験管に加え、撹拌した。この操作を同様に3〜5番目の試験管に順に行った。1、3、5番目の試験管中の培養液を撹拌後、10%綿羊脱繊血含有トリプチケースソイ寒天平板(Difco社製)に50μL塗沫し、嫌気条件下で培養した。生育したコロニーを計測し、残存するストレプトコッカス ミュータンス菌の生菌数(cfu)を求め、下記の基準に則り、浮遊菌殺菌効果を判定した。
判定基準:
◎:生菌数が102未満
○:生菌数が102以上103未満
△:生菌数が103以上104未満
×:生菌数が104以上
(3) Evaluation method of bactericidal effect on oral cavity floating bacteria As a culture solution, a solution obtained by dissolving 30 g of trypticase soy broth (manufactured by Difco) in 1 L of purified water is used as Streptococcus as an oral cavity resident bacteria. Prepared by adding saline so that the permeability at 550 nm of the solution cultured for 1 day under anaerobic conditions (5% by volume carbon dioxide, 95% by volume nitrogen) at 37 ° C. using mutans ATCC 10449 strain is 20. did. 0.3 mL of bacterial solution is added to 2.7 mL of a sample (liquid oral composition), stirred, reacted at 37 ° C. for 1 minute, stirred again, and five test tubes containing 2.7 mL of culture fluid in advance In the first test tube, 0.3 mL of the sample to which the bacterial solution was added was added and stirred. 0.3 mL of this solution was collected, added to a second test tube and stirred. This operation was similarly performed to the third to fifth test tubes in order. After stirring the culture solutions in the first, third and fifth test tubes, 50 μL of the culture solution was smeared on trypticase soy agar plates (manufactured by Difco) containing 10% cotton defibrillated blood and cultured under anaerobic conditions. The grown colonies were counted to determine the viable count (cfu) of the remaining Streptococcus mutans bacteria, and the bactericidal activity was determined based on the following criteria.
Judgment criteria:
:: viable count is less than 10 2 ○: viable count is 10 2 to 10 3 Δ: viable count is 10 3 to 10 4 ×: viable count is 10 4 or more

(4)使用感(苦味のなさ)の評価方法
表に記載の各洗口剤10mLを口に含み、30秒間すすいだ後、洗口後の苦味について判定士5名が下記の評点基準により判定した。5名の平均値を求め、下記の評価基準に従って評価した。
評点基準:
4点:苦味がなかった
3点:苦味がほとんどなかった
2点:苦味がややあった。
1点:苦味がかなりあった
使用感(洗口後の苦味のなさ)の評価基準:
◎:平均点3.5点以上4.0点以下
○:平均点3.0点以上3.5点未満
△:平均点2.0点以上3.0点未満
×:平均点2.0点未満
(4) Evaluation method for feeling in use (no bitterness) 10 mL of each mouthwash described in the table is included in the mouth, and after rinsing for 30 seconds, five judges judged the bitterness after mouth rinsing according to the following rating criteria did. The average value of 5 persons was determined and evaluated according to the following evaluation criteria.
Rating criteria:
4 points: There was no bitterness 3 points: There was almost no bitterness 2 points: There was some bitterness.
1 point: Bitterness was considerable. Evaluation criteria (no bitterness after mouth washing) Evaluation criteria:
A: Average point 3.5 or more and 4.0 or less ○: Average point 3.0 or more and less than 3.5 points Δ: Average point 2.0 or more and less than 3.0 points ×: Average point 2.0 Less than

使用原料の詳細を下記に示す。
(A)硝酸カリウム;硝酸カリウムスーパータブレット(大塚食品化学社製)
(B)塩化セチルピリジニウム;塩化セチルピリジニウム(和光純薬工業社製)
(C)ポリオキシエチレン(100)硬化ヒマシ油;
エチレンオキサイドの平均付加モル数100(日光ケミカルズ社製)
ポリオキシエチレン(40)硬化ヒマシ油;
エチレンオキサイドの平均付加モル数40(日光ケミカルズ社製)
(D)アルキルアミドベタイン;
ヤシ油脂肪酸アミドプロピルベタインの30%水溶液、TEGO Betain
CK OK(デグッサ社製)
なお、表中も含め、アルキルアミドベタインの配合量は、純分換算値である(以下、同様。)。
Details of the raw materials used are shown below.
(A) potassium nitrate; potassium nitrate super tablet (manufactured by Otsuka Food Chemicals Co., Ltd.)
(B) cetyl pyridinium chloride; cetyl pyridinium chloride (manufactured by Wako Pure Chemical Industries, Ltd.)
(C) polyoxyethylene (100) hydrogenated castor oil;
Average added mole number of ethylene oxide 100 (manufactured by Nikko Chemicals)
Polyoxyethylene (40) hydrogenated castor oil;
Average added mole number of ethylene oxide 40 (manufactured by Nikko Chemicals Co., Ltd.)
(D) alkylamido betaines;
30% aqueous solution of coconut oil fatty acid amidopropyl betaine, TEGO Betain
CK OK (made by Degussa)
In addition, the compounding quantity of the alkylamide betaine also in the table | surface is a pure part conversion value (following, the same).

Figure 0006547324
Figure 0006547324


Figure 0006547324
*;比較例8のエタノール配合組成では、(A)、(B)成分が配合されていても不溶性沈殿物の析出がなく、知覚過敏抑制効果、浮遊菌殺菌効果が低下することもなかった。
Figure 0006547324
*: In the ethanol-blended composition of Comparative Example 8, even when the components (A) and (B) were blended, there was no precipitation of the insoluble precipitate, and the hypersensitivity-suppressing effect and the suspended germ killing effect did not decrease either.

以下、処方例を示す。使用原料は上記と同様である。この洗口剤は、外観安定性(析出抑制効果)、知覚過敏抑制効果、浮遊菌殺菌効果、使用感(苦味のなさ)が全て優れた。   An example of prescription is shown below. The raw materials used are the same as above. This mouthwash was all excellent in appearance stability (precipitation suppressing effect), hypersensitivity suppressing effect, floating bacteria killing effect and feeling in use (no bitter taste).

[処方例]洗口剤
(A)硝酸カリウム 5.0%
(B)塩化セチルピリジニウム 0.05
(C)ポリオキシエチレン(60)硬化ヒマシ油 0.5
(D)アルキルアミドベタイン 0.3
グリセリン 3.0
プロピレングリコール 8.0
サッカリンナトリウム 0.1
リン酸二水素ナトリウム 0.5
水酸化ナトリウム 0.16
香料 0.2
精製水 82.19
計 100.0%
pH 6.8
[Formulation example] mouthwash (A) potassium nitrate 5.0%
(B) cetyl pyridinium chloride 0.05
(C) Polyoxyethylene (60) hydrogenated castor oil 0.5
(D) alkylamido betaine 0.3
Glycerin 3.0
Propylene glycol 8.0
Saccharin sodium 0.1
Sodium dihydrogen phosphate 0.5
Sodium hydroxide 0.16
Fragrance 0.2
Purified water 82.19
100.0% in total
pH 6.8

Claims (5)

(A)硝酸カリウムを0.01〜10質量%及び(B)塩化セチルピリジニウムを0.001〜0.1質量%配合したエタノール無配合の液体口腔用組成物に、
(C)エチレンオキサイドの平均付加モル数が40〜100モルのポリオキシエチレン硬化ヒマシ油を0.2〜2質量%、及び
(D)アルキルアミドベタイン又はその塩を0.2〜2質量%
配合し、(E)水分量を55質量%以上92質量%未満とし、組成物の25℃におけるpHを6.8以上8.0未満としたことを特徴とする液体口腔用組成物。
A liquid oral composition containing no (A) potassium nitrate in an amount of 0.01 to 10% by mass and (B) cetylpyridinium chloride in an amount of 0.001 to 0.1% by mass.
(C) the average number of moles of added ethylene oxide is 40 to 100 moles of polyoxyethylene hydrogenated castor oil 0.2 to 2% by weight, and (D) an alkyl amido betaine or a salt thereof from 0.2 to 2 wt%
(E) A composition for liquid oral cavity comprising: (E) a water content of 55% by mass to less than 92% by mass, and a pH of the composition at 25 ° C. of 6.8 to less than 8.0.
(D)アルキルアミドベタイン又はその塩が、ヤシ油脂肪酸アミドプロピルベタインである請求項1記載の液体口腔用組成物。   The liquid oral cavity composition according to claim 1, wherein the alkylamide betaine (D) or a salt thereof is coconut oil fatty acid amidopropyl betaine. 洗口剤である請求項1又は2記載の液体口腔用組成物。   The composition for liquid oral cavity according to claim 1 or 2, which is a mouthwash. 知覚過敏及びう蝕抑制用である請求項1〜3のいずれか1項記載の液体口腔用組成物。   The composition for liquid oral cavity according to any one of claims 1 to 3, which is for hypersensitivity and caries inhibition. (A)硝酸カリウムを0.01〜10質量%及び(B)塩化セチルピリジニウムを0.001〜0.1質量%配合したエタノール無配合の液体口腔用組成物に、
(C)エチレンオキサイドの平均付加モル数が40〜100モルのポリオキシエチレン硬化ヒマシ油を0.2〜2質量%、及び
(D)アルキルアミドベタイン又はその塩を0.2〜2質量%
配合し、(E)水分量を55質量%以上92質量%未満とし、組成物の25℃におけるpHを6.8以上8.0未満とすることを特徴とする、前記液体口腔用組成物における(A)硝酸カリウム及び(B)塩化セチルピリジニウムの併用によって生じる不溶性沈殿物の析出抑制方法。
A liquid oral composition containing no (A) potassium nitrate in an amount of 0.01 to 10% by mass and (B) cetylpyridinium chloride in an amount of 0.001 to 0.1% by mass.
(C) the average number of moles of added ethylene oxide is 40 to 100 moles of polyoxyethylene hydrogenated castor oil 0.2 to 2% by weight, and (D) an alkyl amido betaine or a salt thereof from 0.2 to 2 wt%
In the composition for a liquid oral cavity, it is characterized in that it is blended, (E) the water content is 55% by mass or more and less than 92% by mass, and the pH of the composition at 25 ° C. is 6.8 or more and less than 8.0. The precipitation suppression method of the insoluble precipitate produced by combined use of (A) potassium nitrate and (B) cetyl pyridinium chloride.
JP2015028458A 2015-02-17 2015-02-17 Liquid oral composition Active JP6547324B2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2015028458A JP6547324B2 (en) 2015-02-17 2015-02-17 Liquid oral composition
PCT/JP2016/054370 WO2016133063A1 (en) 2015-02-17 2016-02-16 Oral liquid composition
CN201680010823.XA CN107249546B (en) 2015-02-17 2016-02-16 Liquid oral composition
KR1020177021898A KR102491340B1 (en) 2015-02-17 2016-02-16 liquid oral composition
MYPI2017702777A MY183114A (en) 2015-02-17 2016-02-16 Oral liquid composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015028458A JP6547324B2 (en) 2015-02-17 2015-02-17 Liquid oral composition

Publications (2)

Publication Number Publication Date
JP2016150912A JP2016150912A (en) 2016-08-22
JP6547324B2 true JP6547324B2 (en) 2019-07-24

Family

ID=56689008

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015028458A Active JP6547324B2 (en) 2015-02-17 2015-02-17 Liquid oral composition

Country Status (5)

Country Link
JP (1) JP6547324B2 (en)
KR (1) KR102491340B1 (en)
CN (1) CN107249546B (en)
MY (1) MY183114A (en)
WO (1) WO2016133063A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6688072B2 (en) * 2015-12-28 2020-04-28 花王株式会社 Liquid oral composition
CN110974724B (en) * 2019-12-30 2023-04-18 重庆登康口腔护理用品股份有限公司 Composition containing hyaluronic acid and preparation method and application thereof
WO2022255124A1 (en) * 2021-06-03 2022-12-08 ライオン株式会社 Liquid composition for oral use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3863006A (en) 1973-01-29 1975-01-28 Milton Hodosh Method for desensitizing teeth
JPH0629177B2 (en) 1984-06-01 1994-04-20 ライオン株式会社 Oral composition
JP3117086B2 (en) * 1990-11-02 2000-12-11 サンスター株式会社 Oral liquid preparation
JPH07101842A (en) 1993-08-12 1995-04-18 Lion Corp Composition for oral cavity
JP3978609B2 (en) 2003-08-25 2007-09-19 ライオン株式会社 Oral composition and method for preventing precipitation of potassium lauryl sulfate in oral composition
JP2007084471A (en) 2005-09-21 2007-04-05 Sunstar Inc Composition for oral cavity and method of selecting product for oral cavity
CN101778618B (en) * 2007-08-09 2012-04-11 狮王株式会社 Liquid oral composition, and method for improvement in bactericidal activity of cationic bactericidal agent
JP2012121833A (en) * 2010-12-08 2012-06-28 Lion Corp Composition for oral cavity and agent for inhibiting fixing of oral cavity disease-causing bacillus to tooth plane
JP2013035792A (en) 2011-08-09 2013-02-21 Kao Corp Composition for oral cavity
JP5830324B2 (en) * 2011-09-21 2015-12-09 ライオン株式会社 Dentifrice composition
JP6138538B2 (en) * 2013-03-25 2017-05-31 サンスター株式会社 Transparent liquid composition for oral cavity

Also Published As

Publication number Publication date
KR102491340B1 (en) 2023-01-26
JP2016150912A (en) 2016-08-22
KR20170117406A (en) 2017-10-23
CN107249546B (en) 2020-07-10
MY183114A (en) 2021-02-15
WO2016133063A1 (en) 2016-08-25
CN107249546A (en) 2017-10-13

Similar Documents

Publication Publication Date Title
JP5573111B2 (en) Isopropylmethylphenol-containing liquid oral composition
JP5874383B2 (en) Oral composition
JP6318487B2 (en) Oral composition
JP6740901B2 (en) Oral composition and method for suppressing taste of cationic bactericide in oral composition
JP5493731B2 (en) Dentifrice composition
JP5842565B2 (en) Mouthwash composition and method for inhibiting discoloration in mouthwash composition
JP6547324B2 (en) Liquid oral composition
CN107205899B (en) Liquid oral composition
WO2019107338A1 (en) Oral composition
JP5493730B2 (en) Dentifrice composition
JP5729291B2 (en) Oral composition
JP5690744B2 (en) Emulsified liquid oral composition and method for producing the same
JP2011046654A (en) Dentifrice composition
JP5825088B2 (en) Liquid oral composition
JP6610001B2 (en) Liquid oral composition
JP2019167297A (en) Dentifrice composition
KR20200093521A (en) Skirt composition
CN109689016B (en) Liquid oral composition
JP5471318B2 (en) Dentifrice composition
WO2022255124A1 (en) Liquid composition for oral use
WO2023100804A1 (en) Liquid composition for oral use
WO2018221615A1 (en) Oral composition
WO2021132169A1 (en) Oral liquid composition
WO2019111723A1 (en) Toothpaste composition
JP2019077630A (en) Composition for oral cavity

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170922

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180724

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180920

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20181204

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190221

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20190301

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190528

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190610

R150 Certificate of patent or registration of utility model

Ref document number: 6547324

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350